Belgium· BE-AMP-SAM135974-00
Silibinine Viatris 350 mg
A other therapeutic products product containing silibinin dihydrogen succinate disodium, registered in Belgium by Viatris Healthcare. The same ATC class is registered in 4 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Silibinin dihydrogen succinate disodium is registered in 4 of 19 countries.
Countries holding a registration under ATC V03AX (other therapeutic products), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Silibinin dihydrogen succinate disodium · ATC V03AX
4 / 19 countries
- Belgiumprice
- Ireland
- Norwayprice
- Polandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Silibinin Dihydrogen Succinate Disodium
- Manufacturer
- Viatris Healthcare
- Country
- Belgium (BE)
- ATC code
- V03AX
- ATC class
- Other therapeutic products
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb3349982
- be_apb0685404
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Silibinin dihydrogen succinate disodium in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandLegalon SIL, Durchstechflasche mit TrockensubstanzViatris Pharma GmbH
- SpainLEGALON 150 mg CAPSULASCooper Consumer Health B.V.
- CzechiaLEGALON SIL
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Hungary · Legalon Sil
- Romania · Silimarina Biofarm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/43ac7464-c636-4b1a-bd12-5879a77910c4 GET /v1/drugs/43ac7464-c636-4b1a-bd12-5879a77910c4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Silibinine Viatris 350 mg",
"name_fr": "Silibinine Viatris 350 mg",
"name_nl": "Silibinine Viatris 350 mg",
"amp_code": "SAM135974-00",
"strengths": [
"528.5000",
"528.5000",
"528.5000",
"528.5000",
"350.0000",
"350.0000",
"350.0000",
"350.0000"
],
"pack_count": 2,
"substances": [
"Silibinin Dihydrogen Succinate Disodium",
"Silibinin"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Other Therapeutic Products",
"authorisation_numbers": [
"BE135974"
]
}See everything about silibinin dihydrogen succinate disodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.